Valeant Pharmaceuticals International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.08.14	Valeant, Pershing Square Allowed Fast-Track Trial Over Allergan Special Meeting (RTTNews)
15.08.14	Valeant Extends Exchange Offer To Acquire Allergan (RTTNews)
05.08.14	Allergan Says Valeant Disclosures Continue To Be Insufficient And Inconsistent (RTTNews)
01.08.14	Allergan Sues Valeant, Ackman Over Insider Trading - Update (RTTNews)
17.07.14	Valeant's Bausch + Lomb Gets FDA Clearance For VICTUS Femtosecond Laser Platform (RTTNews)
08.07.14	Valeant Completes Acquisition Of PreCision Dermatology (RTTNews)
23.06.14	Allergan Urges Shareholders Not To Tender Shares To Valeant Exchange Offer (RTTNews)
23.06.14	Allergan Rejects Valeant's Tender Offer - Quick Facts (RTTNews)
18.06.14	Valeant's Tender Offer For Allergan Begins (RTTNews)
16.06.14	Valeant Wins FDA Marketing Clearance For Restylane Silk - Quick Facts (RTTNews)
14.06.14	Valeant Pharma Says Ryan Weldon To Leave After Skin Care Rights' Sale To Nestle (RTTNews)
13.06.14	Ackman's Pershing Square Files Suit Against Allergan On Poison Pill Trigger (RTTNews)
02.06.14	Pershing Square Seeks To Remove Six Allergan Directors (RTTNews)
28.05.14	UPDATE: MÄRKTE USA/Nach erneutem Allzeithoch läuft die Rally aus (Dow Jones)
28.05.14	MÄRKTE USA/Nach erneutem Allzeithoch läuft die Rally aus (Dow Jones)
28.05.14	Valeant Pharma To Sell Filler & Toxin Assets To Nestle For $1.4 Bln Cash (RTTNews)
21.05.14	Pershing Square Capital Releases Letter In Response To Allergan (RTTNews)
12.05.14	Valeant Pharma Enters Into Patent Settlement Agreements With Actavis (RTTNews)
12.05.14	Allergan Rejects Valeant Offer, Says Stock Part Risk For Shareholders (RTTNews)
10.05.14	Allergan Plans To Reject Valeant's C$46 Bln Offer : Report (RTTNews)
08.05.14	Valeant Pharma Q1 Loss Narrows (RTTNews)
08.05.14	Earnings Watch For May 8 (DISH, PCLN, MDRX, CBS, CSC, NWS) (RTTNews)
22.04.14	Allergan Confirms Acquisition Proposal From Valeant Pharma - Quick Facts (RTTNews)
22.04.14	Valeant Proposes To Buy Botox Maker Allergan, Lifts Forecast (RTTNews)
27.02.14	Valeant Pharma Swings To Q4 Profit, Reaffirms 2014 Outlook (RTTNews)
03.02.14	Valeant Pharma To Buy Precision Dermatology For $475 Mln - Quick Facts (RTTNews)
17.12.13	ADHD Gets Attention, BioLife To Uplist Stock, TRGT Misses Goal, CEMP On A High (RTTNews)
16.12.13	Valeant Pharma To Acquire Solta Medical For About $250 Mln - Quick Facts (RTTNews)
25.11.13	Valeant Pharma: Ari Kellen To Become EVP/Company Group Chairman - Quick Facts (RTTNews)
15.11.13	Valeant Says FDA Approves Luzu Cream, 1% (RTTNews)
28.10.13	Actavis Files ANDA For Generic Version Of Acanya Gel - Quick Facts (RTTNews)
28.10.13	Anacor Settles With Valeant Related To All Outstanding Litigation - Quick Facts (RTTNews)
18.10.13	Valeant Pharmaceuticals Announces Award In Anacor Dispute (PR Newswire)
18.10.13	Anacor Vs. Valeant: The Verdict Is In (RTTNews)
15.10.13	Collaborations, Survey Results, Appointments, and Approvals - Research Report on Merck, Aetna, HCA, Medtronic, and Valeant Pharmaceuticals (PR Newswire)
07.10.13	Partnerships, Product Recall, New Contracts, Promotions, and Stock Movement - Research Report on Valeant, CareFusion, Envision Healthcare, Seattle Genetics, and Osiris (PR Newswire)
03.10.13	Valeant Pharmaceuticals' Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens (PR Newswire)
03.10.13	Valeant Pharmaceuticals Announces Approval Of Jublia® For The Treatment Of Onychomycosis In Canada (PR Newswire)
27.09.13	Under AAAResearchReports.com Microscope: Zoetis Inc., Teva Pharma Industries Ltd, Covidien PLC, and Valeant Pharma Intl. Inc. (PR Newswire)
21.08.13	Technical Study: Zoetis Inc., Teva Pharma Industries Ltd, Covidien plc, and Valeant Pharma Intl. Inc. (PR Newswire)
12.08.13	Financial Results Release, Management Changes, and Newly Issued Permits - Research Report on Valeant, Teva, Endo, Array, and Sequenom (PR Newswire)
10.08.13	Valeant Pharmaceuticals Announces Continuance (PR Newswire)
07.08.13	Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results (PR Newswire)
23.07.13	FDA Designations to Development Programs and Quarterly Financial Results Schedules - Research Report on Valeant, Elan, Alkermes, Teva and Gilead (PR Newswire)
15.06.12	Wall Street Schluss: US-Börsen schliessen vor Griechenland-Wahlen fester, Hoffnung auf die Notenbanken (Aktiencheck)
15.06.12	Wall Street Update: Weitere Zugewinne, Hoffnung auf die Notenbanken (Aktiencheck)
15.06.12	Wall Street Eröffnung: Grüne Vorzeichen trotz schwacher Konjunkturdaten (Aktiencheck)
15.06.12	Valeant Pharmaceuticals: Übernahme von OraPharma (Aktiencheck)
30.01.12	Valeant Pharmaceuticals zieht Offerte für ISTA Pharmaceuticals zurück (Aktiencheck)
06.01.12	Valeant Pharmaceuticals erwartet Gewinnanstieg in 2012 (Aktiencheck)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Valeant Pharmaceuticals International Inc.

Aktien Top/Flop

Meistgelesene Nachrichten